Characterization of Dermal Reactions in Pediatric Patients With ADHD Using DAYTRANA
Public ClinicalTrials.gov record NCT00434213. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase IV, Multi-center, Open-label Study of DAYTRANA (Methylphenidate Transdermal System [MTS]) to Characterize the Dermal Reactions in Pediatric Patients Aged 6-12 With Attention Deficit/Hyperactivity Disorder (ADHD).
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a study designed to characterize the dermal response of DAYTRANA. Subjects will visit the study site over a period of approximately 14 weeks.
Study identification
- NCT ID
- NCT00434213
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 309 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 6 Years to 12 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 31, 2006
- Primary completion
- Jul 31, 2007
- Completion
- Jun 30, 2008
- Last update posted
- Apr 25, 2017
2007 – 2008
United States locations
- U.S. sites
- 29
- U.S. states
- 18
- U.S. cities
- 29
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Scottsdale | Arizona | — | — |
| Not listed | Irvine | California | — | — |
| Not listed | San Marcos | California | — | — |
| Not listed | Spring Valley | California | — | — |
| Not listed | Wildomar | California | — | — |
| Not listed | Boulder | Colorado | — | — |
| Not listed | Gainesville | Florida | — | — |
| Not listed | Miami | Florida | — | — |
| Not listed | Winter Park | Florida | — | — |
| Not listed | Libertyville | Illinois | — | — |
| Not listed | Northbrook | Illinois | — | — |
| Not listed | Overland Park | Kansas | — | — |
| Not listed | Bardstown | Kentucky | — | — |
| Not listed | Owensboro | Kentucky | — | — |
| Not listed | Cambridge | Massachusetts | — | — |
| Not listed | Kalamazoo | Michigan | — | — |
| Not listed | Las Vegas | Nevada | — | — |
| Not listed | Toms River | New Jersey | — | — |
| Not listed | Rochester | New York | — | — |
| Not listed | Cleveland | Ohio | — | — |
| Not listed | Columbus | Ohio | — | — |
| Not listed | Portland | Oregon | — | — |
| Not listed | Salem | Oregon | — | — |
| Not listed | Philadelphia | Pennsylvania | — | — |
| Not listed | Jackson | Tennessee | — | — |
| Not listed | Austin | Texas | — | — |
| Not listed | Lubbock | Texas | 79423 | — |
| Not listed | San Antonio | Texas | — | — |
| Not listed | Norfolk | Virginia | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00434213, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 25, 2017 · Synced Sep 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00434213 live on ClinicalTrials.gov.